Trinucleotide repeat disorders

被引:1061
作者
Orr, Harry T. [1 ]
Zoghbi, Huda Y.
机构
[1] Univ Minnesota, Inst Human Genet, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA
[6] Howard Hughes Med Inst, Houston, TX 77030 USA
关键词
unstable repeats; ataxia; Huntington disease; fragile X syndrome; mental retardation; myotonic dystrophy; spinal bulbar muscular atrophy; ataxin; frataxin; polyglutamine;
D O I
10.1146/annurev.neuro.29.051605.113042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The discovery that expansion of unstable repeats can cause a variety of neurological disorders has changed the landscape of disease-oriented research for several forms of mental retardation, Huntington disease, inherited ataxias, and muscular dystrophy. The dynamic nature of these mutations provided an explanation for the variable phenotype expressivity within a family. Beyond diagnosis and genetic counseling, the benefits from studying these disorders have been noted in both neurobiology and cell biology. Examples include insight about the role of translational control in synaptic plasticity, the role of RNA processing in the integrity of muscle and neuronal function, the importance of Fe-S-containing enzymes for cellular energy, and the dramatic effects of altering protein conformations on neuronal function and survival. It is exciting that within a span of 15 years, pathogenesis studies of this class of disorders are beginning to reveal pathways that are potential therapeutic targets.
引用
收藏
页码:575 / 621
页数:47
相关论文
共 305 条
  • [1] Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cell degeneration in transgenic mice
    Aguiar, J
    Fernández, J
    Aguilar, A
    Mendoza, Y
    Vázquez, M
    Suárez, J
    Berlanga, J
    Cruz, S
    Guillén, G
    Herrera, L
    Velázquez, L
    Santos, N
    Merino, N
    [J]. NEUROSCIENCE LETTERS, 2006, 392 (03) : 202 - 206
  • [2] Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO
  • [3] 2-B
  • [4] RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila
    Anderson, PR
    Kirby, K
    Hilliker, AJ
    Phillips, JP
    [J]. HUMAN MOLECULAR GENETICS, 2005, 14 (22) : 3397 - 3405
  • [5] HEAT REPEATS IN THE HUNTINGTONS-DISEASE PROTEIN
    ANDRADE, MA
    BORK, P
    [J]. NATURE GENETICS, 1995, 11 (02) : 115 - 116
  • [6] A FAMILY WITH ADULT SPINAL AND BULBAR MUSCULAR-ATROPHY, X-LINKED INHERITANCE AND ASSOCIATED TESTICULAR FAILURE
    ARBIZU, T
    SANTAMARIA, J
    GOMEZ, JM
    QUILEZ, A
    SERRA, JP
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 59 (03) : 371 - 382
  • [7] Friedreich's ataxia:: Idebenone treatment in early stage patients
    Artuch, R
    Aracil, A
    Mas, A
    Colomé, C
    Rissech, M
    Monrós, E
    Pineda, M
    [J]. NEUROPEDIATRICS, 2002, 33 (04) : 190 - 193
  • [8] Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin
    Babcock, M
    deSilva, D
    Oaks, R
    DavisKaplan, S
    Jiralerspong, S
    Montermini, L
    Pandolfo, M
    Kaplan, J
    [J]. SCIENCE, 1997, 276 (5319) : 1709 - 1712
  • [9] Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse
    Bakker, CE
    Otero, YD
    Bontekoe, C
    Raghoe, P
    Luteijn, T
    Hoogeveen, AT
    Oostra, BA
    Willemsen, R
    [J]. EXPERIMENTAL CELL RESEARCH, 2000, 258 (01) : 162 - 170
  • [10] BAKKER CE, 1994, CELL, V78, P23